CHRISTINA VAUGHAN: Open Payments
NPI 1760253637 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 21 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $857 · 2025 $586
Food & beverage: $587
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $267 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $91 |
| Esperion Therapeutics, Inc. | 4 | $76 |
| Amgen Inc. | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: LOKELMA, FARXIGA, LifeVest, NEXLETOL, REPATHA, VERQUVO, JARDIANCE, Kerendia.
Industry payments across FL — which companies pay providers there.
